← Back to Patent Explorer
US3674865A Expired / Lapsed US ⏱️ 0.0 years remaining

Procedure for obtaining pituitary gonadotropic hormones from urine

Assignee: Merck Serono SpA
•
Filing: 1970-05-11
•
Granted: 1972-07-04
•
Expires: 1990-05-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for the preparation of a urinary gonadotropic hormone preparation containing FSH and LH hormones, the weight ratio of FSH:LH being at least 3:1 by extracting said hormones from menopausal or post-menopausal urine.

Inventors

  • 👤 Pietro Donini

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 23:33
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/22; A61K38/24; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/834

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 93 words
The process of claim 1 which includes: v. dissolving the precipitate from (u) in water; w. passing the dissolved precipitate from (v) at a temperature of 4.5* C. through a column containing small grains of a hydrophilic, insoluble material made by cross-linking polysaccharide dextran wherein the dextran chains are cross-linked to give a three dimensional network and the functional ionic groups are attached to the glucose units of the polysaccharide chains by ether linkages; and x. collecting the first fractions passing through said column to provide a further purified urinary gonadotropic hormone preparation.
Claim 2
Dependent Claim 54 words
A pituitary gonadotropic hormone preparation made in accordance with claim 1 and characterized by the following biological activities; Total Gonadotropic Activity (mouse uterus test) 1 mg 141 mg equivalent of I.R.P. FSH (augmentation test in rats) 1 mg 621 equivalents of I.R.P. LH (central prostrate wt. hypophysectomized rats) 1 mg 115 mg equivalent I.R.P.
Claim 3
Independent Claim 410 words
A method for the preparation of a urinary gonadotropic hormone preparation containing FSH and LH hormones, the ratio of FSH:LH being between 3:1 and 6:1 which comprises: a. acidifying menopausal or post-menopausal human urine to a pH between 4.0 and 4.5; b. adding thereto an aqueous suspension of activated kaolin present in amounts of 10-30 percent by weight of said suspension; c. agitating the resulting mixture for a period of about 1 hour; d. separating the said activated kaolin adsorbent from the mixture by settling; e. discarding the supernatant liquid; f. centrifuging the separated activated kaolin adsorbent; g. washing the centrifuged activated kaolin adsorbent twice with acidulated water at a pH of about 4.5; h. eluting the washed activated kaolin adsorbent twice with 1 M aqueous ammonia solution so as to obtain an eluate at a pH between 11.0 and 11.3; i. mixing the eluates from (h); j. adjusting the pH of the mixed eluates to about 8.5 thereby forming a precipitate; k. separating the precipitate of (j) from the mixed eluates to provide a relatively clear liquid; l. acidifying said relatively clear liquid to a pH of about 5.0 to 5.5; m. adding to the acidified clear liquid of (l) about 2 volumes of acetone and maintaining the mixture overnight to form a precipitate; n. separating the precipitate of (l) from the acetone treated clear liquid; o. drying the precipitate; p. washing the precipitate with about 95 percent ethanol and ether; q. extracting the washed precipitate with about 70 percent ethanol containing about 10 percent ammonium acetate to obtain a relatively cleAr extract; r. adding to the extract of (q) absolute ethanol containing about 10 percent ammonium acetate to produce a precipitate; s. dissolving the precipitate from (r) with a 0.05 M phosphate buffer at a pH of about 7; t. stirring the dissolved precipitate from (s) with diethylaminoethyl cellulose and thereafter separating said diethylaminoethyl cellulose therefrom to form a relatively clear filtrate; u. acidifying the relatively clear filtrate from (t) to pH 5.4; v. passing said acidified relatively clear filtrate through a column containing synthetic alumino-silicate gel equilibrated with 0.05 M acetate buffer at a pH of about 5.4; w. eluting the column with 40 percent ethanol containing 10 percent ammonium acetate to provide an eluate; x. adding to the eluate of (w) about 95 percent ethanol in amounts sufficient to form a precipitate; and y. washing the precipitate from (x) to provide said urinary gonadotropic hormone preparation.
Claim 4
Dependent Claim 14 words
The process of claim 4 wherein the acid used for acidification is acetic acid.
Claim 5
Dependent Claim 19 words
The process of claim 4 wherein the kaolin is previously washed with about normal HCl and washed with water.
Claim 6
Dependent Claim 33 words
The process of claim 4 wherein the diethylaminoethyl cellulose used is previously treated with 0.5 N HCl, then with 0.5 N sodium hydroxide and finally with 0.05 M phosphate buffer of pH 7.0.
Claim 7
Dependent Claim 38 words
The process of claim 4 wherein the synthetic alumino-silicate gel has a granular size passing through 56 mesh and retained by a 76 mesh sieve and which has been previously washed with acetic acid, with water and dried.

References Cited (Backward Citations)

US3457346A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1975-07-04 1976-01-03 1976-07-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1979-07-04 1980-01-03 1980-07-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1983-07-04 1984-01-03 1984-07-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag